Elan Maxipime Shortage Due To Manufacturing Suspension
This article was originally published in The Pink Sheet Daily
Executive Summary
Maxipime manufacturer Bristol-Myers Squibb says it temporarily stopped manufacturing cefepime in January due to documentation issues related to bulk manufacturing. FDA accepts Bristol request to release additional product under an amended filing April 12, Bristol says.You may also be interested in...
Prialt Sales Sluggish, But Elan Expects Rapid Growth
NME Slowdown Shows Market Pressure On Me-Toos, Not FDA Caution – Lutter
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: